Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Accrued Liabilities

v3.10.0.1
Note 5 - Accrued Liabilities
9 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
5.
Accrued Liabilities
 
Accrued liabilities consisted of the following as of
September 30, 2018
and
December 31, 2017 (
in thousands): 
 
   
September 30,
   
December 31,
 
   
2018
   
2017
 
                 
Accrued sales commission
  $
1,292
    $
1,067
 
Accrued bonuses
   
922
     
1,597
 
Accrued interest
   
676
     
447
 
Accrued payroll and other related expenses
   
527
     
488
 
Accrued professional fees
   
386
     
562
 
Customer contracts liabilities
   
334
     
-
 
Travel and entertainment
   
230
     
156
 
Accrued sales & use tax
   
143
     
149
 
Accrued clinical trial costs
   
76
     
30
 
Other accruals
   
539
     
109
 
Total accrued liabilities
  $
5,125
    $
4,605